Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

American Urological Association Announces 2025 Innovation Nexus Showcase Selections The American Urological Association (AUA) ...

JELMYTO, a mitomycin-containing reverse thermal gel, is designed to treat adult ... low-grade intermediate-risk non-muscle-invasive bladder cancer, has shown a high response rate.

For many, a cup of coffee isn’t complete without a creamer. And finding the right creamer can be just as important as the ...

In October 2024, Lutris successfully completed enrollment in the international phase 2 trial of LUT014 in patients with metastatic colorectal cancer (mCRC) treated with EGFRi therapy who develop ...

It can be awkward (picture an hourlong gynecological exam, but friendlier), but it’s an underrated option for perimenopausal ...

A water-based saliva replacement gel can help with dry lips and a dry mouth. Your GP or district nurse can provide this. The dying person might lose control of their bladder and bowel ... contact ...

DMSO is indicated by the Food and Drug Administration for the symptomatic relief of interstitial cystitis, a chronic and ...

This research aims to construct an effective prediction model for the prognosis of bladder cancer (BC) based on glycometabolism ... The total proteins were separated by SDS-PAGE gel (12%) and passed ...